Wolters Kluwer Health today announced the availability of Medi-Span® Vet Meds, an embedded drug data and screening solution to help U.S. pharmacies seamlessly expand to serve pet owners by providing veterinary prescriptions at the same place where they pick up their own medications. Built specifically for retail pharmacies, pharmacy partners, and veterinary medication fulfillment organizations, the solution powers animal-specific medication screening at scale for greater consistency, efficiency, and safety.
Pet parents want convenience and safety with pet medicines
A new Wolters Kluwer survey of U.S. pet owners* points to a clear opportunity for pharmacies expanding into veterinary prescriptions. While 75% of consumers surveyed would like to fill pet prescriptions through the same channels they use for family medications, 80% say pharmacists having access to pet-specific medication safety information is important.
Evolving to capture a growing veterinary medicine market
As veterinary medications move into retail pharmacy, fulfillment, and digital pet medication channels, many dispensing systems are still built only for human medications. As a result, veterinary prescriptions often require pharmacists to rely on manual references or screening tools designed for human medications. These gaps can pull pharmacists out of their usual workflow, increasing the potential for inconsistencies and clinical risk, especially as animal prescription volumes grow.
“For decades, healthcare organizations have relied on Medi-Span for trusted medication intelligence that supports efficient medication decision-making,” said Chris Sullivan, Vice President and General Manager, Pharmacy and Health Technology Solutions, Wolters Kluwer Health. “Medi-Span Vet Meds extends that trusted foundation into veterinary care, helping pharmacies expand into a growing market with purpose-built medication intelligence designed specifically for veterinary prescribing and dispensing.”
What sets Medi-Span pet medication resources apart?
The Medi-Span suite of drug databases and APIs has been trusted across the healthcare ecosystem for over 50 years to efficiently and dependably support medication-related decision-making, support compliance, and drive scalable digital health tech innovation. Medi-Span Vet Meds uses structured, machine-readable veterinary drug data and species-specific screening rules that account for differences in dosing ranges, toxicities, contraindications, and drug interactions across animal species. Supported by Medi-Span’s governed clinical data stewardship processes, the solution delivers repeatable screening designed for enterprise dispensing environments.
Learn more about Medi-Span Vet Meds.
*This survey, conducted by Wolters Kluwer in July 2026, is among 2,000 adults who are U.S. adults, 18 and older, and is weighted by age, gender, household income, region and education to be representative of the total U.S. population according to the U.S. Census Bureau, of whom 1,336 are pet owners.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare, tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2025 annual revenues of €6.1 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,100 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50, and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, and follow us on LinkedIn, Facebook, YouTube, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260811218881/en/
Media gallery
